Aberrant Growth in 5-Year-Old Children After Antibiotics in the First Week of Life
- PMID: 41057288
- DOI: 10.1111/apa.70322
Aberrant Growth in 5-Year-Old Children After Antibiotics in the First Week of Life
Abstract
Aim: We examined the relationship between early-life antibiotics, different regimens, and growth until age five years.
Methods: Data from two parallel birth cohorts were analysed: 128 healthy term-born children and 147 term-born children who received antibiotics for suspected neonatal sepsis, randomised across three regimens: Amoxicillin+Cefotaxime, Augmentin+Gentamicin, Penicillin+Gentamicin. Until age five years, growth, environmental exposures, diet, and physical activity data were collected. Primary outcomes were weight-for-age, height-for-age, and weight-for-height z-scores with early-life antibiotic exposure and the regimen as determinants of interest.
Results: The median antibiotic exposure duration was 3 days (interquartile range 2.4-5.5 days). Children exposed to early-life antibiotics had on average 0.26 lower weight-for-height z-scores over the first five years compared to unexposed controls (p = 0.014). Especially children treated with Augmentin+Gentamicin showed lower weight-for-height z-scores, compared to unexposed controls (coefficient = 0.36; p = 0.013). Additionally, at age five years, higher birth weight percentiles were associated with higher weight-for-age, height-for-age and weight-for-height and weekly lemonade consumption was associated with higher weight-for-age z-scores.
Conclusion: Antibiotics in the first week of life are associated with lower weight-for-height up to age five years, with effects varying by treatment type. To explain these effects, further examination of antimicrobial-induced early-life microbiome perturbations and subsequent growth is needed.
Trial registration: International Clinical Trial Registry Platform (https://trialsearch.who.int/): NL4882 and NL3821.
Keywords: anti‐bacterial agents; growth and development; neonatal early‐onset sepsis.
© 2025 The Author(s). Acta Paediatrica published by John Wiley & Sons Ltd on behalf of Foundation Acta Paediatrica.
References
-
- J. Schulman, R. J. Dimand, H. C. Lee, G. V. Duenas, M. V. Bennett, and J. B. Gould, “Neonatal Intensive Care Unit Antibiotic Use,” Pediatrics 135, no. 5 (2015): 826–833.
-
- S. J. Schrag, M. M. Farley, S. Petit, et al., “Epidemiology of Invasive Early‐Onset Neonatal Sepsis, 2005 to 2014,” Pediatrics 138, no. 6 (2016): e20162013.
-
- C. Klingenberg, R. F. Kornelisse, G. Buonocore, R. F. Maier, and M. Stocker, “Culture‐Negative Early‐Onset Neonatal Sepsis—At the Crossroad Between Efficient Sepsis Care and Antimicrobial Stewardship,” Frontiers in Pediatrics 6 (2018): 285.
-
- L. Snoek, M. N. van Kassel, J. F. Krommenhoek, et al., “Neonatal Early‐Onset Infections: Comparing the Sensitivity of the Neonatal Early‐Onset Sepsis Calculator to the Dutch and the Updated NICE Guidelines in an Observational Cohort of Culture‐Positive Cases,” EClinicalMedicine 44 (2022): 101270.
-
- Richtlijn – NVK [Internet], https://www.nvk.nl/themas/kwaliteit/richtlijnen/richtlijn?componentid=68....
Grants and funding
LinkOut - more resources
Full Text Sources